Inhibition of GABA system involved in cyclosporine-induced convulsions

Life Sciences

Volumn 65, Issue 9, 1999, Pages 879-887

  Shuto, Hideki ^a   Kataoka, Yasufumi ^a   Fujisaki, Koji ^a   Nakao, Takako ^a   Sueyasu, Masanori ^a   Miura, Izumi ^b   Watanabe, Yasuo ^c   Fujiwara, Michihiro ^b   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

3H muscimol binding; Convulsion; Cultured rat cerebellar granule cells; Cyclosporine; GABA turnover; GABAA receptor

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; CYCLOSPORIN; DIAZEPAM; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; PHENOBARBITAL; QUISQUALIC ACID; STRYCHNINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBELLUM; CONVULSION; GABAERGIC SYSTEM; GRANULAR CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN;

ANIMALS; ANTICONVULSANTS; BICUCULLINE; BINDING SITES; BRAIN; CELLS, CULTURED; CEREBELLUM; CYCLOSPORINE; DRUG SYNERGISM; EXCITATORY AMINO ACID AGONISTS; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLYCINE; MALE; MICE; MICE, INBRED STRAINS; MUSCIMOL; NEURONS; RATS; RATS, WISTAR; SEIZURES; STRYCHNINE; TACROLIMUS;

EID: 0033597753     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00318-5     Document Type: Article

References (27)

1. B.D. Kahan, N. Engl. J. Med. 321 1725-1738 (1989).
2. M. Hauben, Pharmacotherapy 16 576-583 (1996).
3. D.H. Adams, S. Ponsford, B. Gunson, A. Boon, L. Honigsberger, A. Williams, J. Buckels, E. Elias and P. McMaster, Lancet 1 949-951 (1987).
4. P.C. De Groen, A.J. Aksamit, J. Rakela, G.S. Forbes and R.A.F. Krom, N. Engl. J. Med. 317 861-866 (1987).
5. R.L. Hughes, N. Engl. J. Med. 323 420-421 (1990).
6. J. Hinchey, C. Chaves, B. Appignani, J. Breen, L. Pao, A. Wang, M.S. Pessin, C. Lamy, J-L. Mas and L.R. Caplan, N. Engl. J. Med. 334 494-500 (1996).
7. L.C. Racusen, B.W. McCrindle, M. Christenson, B. Fivush and R.S. Fisher, Life Sci. 46 1021-1026 (1990).
8. L. Famiglio, L. Racusen, B. Fivush, K. Solez and R. Fisher, Transplantation 48 316-321 (1989).
9. J.T. Blair, A.W. Thomson, P.H. Whiting, R.J.L. Davidson and J.G. Simpson, J. Pathology 138 163-178 (1982).
10. H. Shuto, Y. Kataoka, A. Kanaya, K. Matsunaga, M. Sueyasu and R. Oishi, Eur. J. Pharmacol. 341 33-37 (1998).
11. F.M. Vaccarino, H. Alho, M.R. Santi and A. Guidotti, J. Neurosci. 7 65-76 (1987).
12. W.J. Loskota, P. Lomax and S.T. Rich, Epilepsia 15 109-119 (1974).
13. J.A.M. Van Der Heyden and J. Korf, J. Neurochem. 31 197-203 (1978).
14. V. Gallo, M.T. Ciotti, A. Coletti, F. Aloisi and G. Levi, Proc. Natl. Acad. Sci. USA. 79 7919-7923 (1982).
15. Y. Kataoka, Y. Kohno and Y. Watanabe, Jpn. J. Pharmacol. 67 87-90 (1995).
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, J. Biol. Chem. 193 256-275 (1951).
17. W. Löscher, Brain Res. 501 198-203 (1989).
18. W. Löscher, D. Hönack and C.P. Taylor, Neurosci. Lett. 128 150-154 (1991).
19. T.M. Dawson, J.P. Steiner, W.E. Lyons, M. Fotuhi, M. Blue and S.H. Snyder, Neuroscience 62 569-580 (1994).
20. J.W. McDonald, M.P. Goldberg, B.J. Gwag, S-I. Chi and D.W. Choi, Ann. Neurol. 40 750-758 (1996).
21. A.M. Rubin and H. Kang, Neurology 37 1072-1076 (1987).
22. A.P. Boon, D.H. Adams, M.P. Carey, A. Williams, P. McMaster and E. Elias, Lancet 1 1457 (1988).
23. M.H. Deierhoi, M. Kalayoglu, H.W. Sollinger and F.O. Belzer, Transplant Proc. 20 116-118 (1988).
24. J.L. Yakel, Trends Pharmacol. Sci. 18 124-134 (1997).
25. S.H. Snyder, D.M. Sabatini, M.M. Lai, J.P. Steiner, G.S. Hamilton and P.D. Suzdak, Trends Pharmacol. Sci. 19 21-26 (1998).
26. J.P. Steiner, T.M. Dawson, M. Fotuhi and S.H. Snyder, Molecular Medicine 2 325-333 (1996).
27. M.V. Jones and G.L. Westbrook, J. Neurosci. 17 7626-7633 (1997).